There are a couple of suggestions to improve the efficiency of anti-covid vaccination in cancer patients, particularly patients with hematologic malignancies, and subsequent to receiving immunosuppressive anti-cancer therapies such as anti-CD20 or anti-CD38 therapies. This evidence concerns the gene CD38 and hematologic disorder.